Fig. 1.
Purification of human PCs from different territories.
The figure shows a representative example of the consecutive steps followed in the protocol used for the purification of PCs from tonsil (CD20/CD38 staining, upper panel), blood (CD19/CD38 staining, middle panel), and BM (CD19/CD38 staining, lower panel). Tonsil CD38h cells were pre-enriched by treatment with anti-CD31 mAb and MACS, and this cell fraction was the starting point in isolating tonsil CD38h cells by FACS. PBMC from tet-immunized volunteers were used in a first step of blood CD38h cell pre-enrichment by treatment with anti-CD19 mAb and MACS. Blood CD38h cells were finally purified from this CD19+ cell fraction by FACS. BM CD38h cells were isolated from BMMCs in a single step by treatment with anti-CD138 mAb and MACS. In the 3 territories CD38h cells were identified as PCs by Giemsa staining as well as intracytoplasmic Ig staining of cytospin preparations of purified CD38h cells (upper and lower photograph, respectively), in each territory. Original magnification × 300.